Page 478 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 478

466        FLUID THERAPY


                          Arginine    Glycine          Guanidinoacetic acid
                             NH 2        H
                             C 
 NH       H–C–NH 2         NH 2
                             NH          COOH    Glycine   C 
 NH
                             CH 2                          NH                     Liver
                             CH 2            Aminotransferase  CH 2
                             CH 2                          COOH
                             H–C–NH 2
                             COOH                                                S-Adenosylmethionine
                                                                   ATP
                                                            Guanidinoacetate
                                                            methyltransferase
                                                                                 S-Adenosylhomosysteine
                                                                   ADP

                                                                             NH 2
                                                                             C 
 NH
                                                                                    Creatine
                                                                             N–CH 3
                                                                             CH 2
                                                                             COOH
                                               H                   Blood              Urine
                                                N  C 
 O
                                         NH 
 C         Creatinine

                                               N    CH 2
                                                CH 3
                                             Muscle
                        Figure 19-8 Diagrammatic representation of hepatic contribution to creatine synthesis. (Adapted from
                        Heymsfield SB, Arteaga C, McManus C, et al. Measurement of muscle mass in humans: validity of the 24-hour
                        urinary creatinine method. Am J Clin Nutr 1983;37:478–494.)




            increased urine NH 4 /NH 3 ratio. Mechanistically, potas-  ATPase that facilitates reabsorption of K in exchange
                             þ
                                                                                                    þ
                                                                      þ 119,154
            sium infused into the hypokalemic patient replaces intra-  for H .  Potassium deficiency also may increase
            cellular hydrogen ions. The displaced cellular hydrogen  luminal electronegativity in the proximal tubule,
                                                                                            31
            ions decrease blood pH, promoting conversion of NH 3  stimulating HCO 3  secretion.  Hypokalemia arising
                                  þ
            to the less-diffusible NH 4 form. This small shift in pH  from  diuretics  used  to  treat  ascites  can  cause
            is not great enough to stimulate renal ammoniagenesis,  hyperammonemia secondary to metabolic alkalosis
                                                                                    þ
            but reduced urine pH leads to increased excretion of  resulting from renal H loss.
                þ
            NH 4 . This effect may be augmented by increased plasma
            aldosteronegivenitsabilitytoincreasehydrogeniondeliv-  Hypophosphatemia in Liver Disease
            ery into distal renal tubular fluid. 188             Hypophosphatemia also may complicate hepatic insuffi-
                                                                 ciency. In human patients, hypophosphatemia and early
            Serum Potassium Concentration and                    phosphorus administration are associated with a good
            Ammoniagenesis                                       prognosis in acute liver failure, whereas hyperpho-
            Experimental and clinical observations of potassium  sphatemia is predictive of poor recovery. 18  Cats with
            depletion and loading suggest that renal NH 3 production  HL  are  at  increased  risk  for  development  of
            is intimately linked with potassium homeostasis. Low  hypophosphatemia, especially when associated with dia-
            serum potassium concentrations stimulate and high    betes mellitus or pancreatitis. Although symptomatic
            serum   potassium  concentrations  suppress  renal   hypophosphatemia may develop after rehydration and
            ammoniagenesis. 154,214  A closed-loop regulatory system  insulin therapy, it is most common as a result of refeeding
                                                                                6
            modulates NH 3 production, hydrogen ion homeostasis,  in cats with HL. Serum potassium, magnesium, and
            and urinary potassium excretion in response to acute  phosphorus concentrations in 157 cats with severe HL
            and chronic changes in serum potassium concentration.  are shown in Figure 19-9. In this population, only 22
            Potassium deficiency stimulates H secretion in the distal  of 157 (14%) HL cats had hypophosphatemia at presen-
                                         þ

            nephron and may stimulate HCO 3    production by     tation, but more than 35% of those undergoing
            increasing collecting duct expression of an H -K -   nutritional support became hypophosphatemic with
                                                       þ
                                                          þ
   473   474   475   476   477   478   479   480   481   482   483